Screener
Precigen PGEN SG&A
SG&A at other companies
Other financials
Where this comes from
Reported directly by Precigen in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Precigen’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356090-26-000017
| (Amounts in thousands, except share and per share data) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating Expenses | ||
| Cost of products and services | 2,559 | 1,100 |
| Research and development | 5,638 | 10,478 |
| Selling, general and administrative | 21,049 | 12,359 |
| Total operating expenses | 29,246 | 23,937 |
| Operating loss | (5,994) | (22,596) |
| Other Income (Expense), Net | ||
| Change in fair value of warrant liabilities | — | (32,481) |
Item 1. Condensed Consolidated Financial Statements
FAQ
- What is Precigen's SG&A?
- Precigen (PGEN) reported SG&A of $21.05M in Q1 2026.
- How has Precigen's SG&A changed year-over-year?
- Precigen's SG&A increased by 70.3% year-over-year, from $12.36M to $21.05M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about Precigen's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude